BCAL financial statements and SEC filings
BCAL annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $180.18M | – | $63.06M | 10-K |
| 2024-12-31 | $127.74M | – | $5.43M | 10-K |
| 2023-12-31 | $97.52M | – | $25.91M | 10-K |
| 2022-12-31 | $91.46M | – | $16.11M | 10-K |
BCAL annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $4.03B | $3.46B | $576.59M | 10-Q |
| 2024-12-31 | $4.03B | $3.52B | $511.84M | 10-K |
| 2023-12-31 | $2.36B | $2.07B | $288.15M | 10-K |
| 2022-12-31 | $2.28B | $2.02B | $260.36M | 10-K |
BCAL annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $57.29M | -$346.00K | -$75.29M | 10-K |
| 2024-12-31 | $50.29M | -$552.00K | -$273.58M | 10-K |
| 2023-12-31 | $33.10M | -$302.00K | $45.86M | 10-K |
| 2022-12-31 | $13.35M | -$1.08M | $6.10M | 10-K |